<author><surname>Ara&#250;jo</surname> <given-names>NC</given-names> </author><author><surname>Barton</surname> <given-names>V</given-names> </author><author><surname>Jones</surname> <given-names>M</given-names> </author><author><surname>Stocks</surname> <given-names>PA</given-names> </author><author><surname>Ward</surname> <given-names>SA</given-names> </author><author><surname>Davies</surname> <given-names>J</given-names> </author><author><surname>Bray</surname> <given-names>PG</given-names> </author><author><surname>Shone</surname> <given-names>AE</given-names> </author><author><surname>Cristiano</surname> <given-names>ML</given-names> </author><author><surname>O'Neill</surname> <given-names>PM</given-names> </author><title>Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates</title><source>Bioorg Med Chem Lett</source><year>2009</year><volume>19</volume><fpage>2038</fpage><lpage>2043</lpage>
<author><surname>Atamna</surname> <given-names>H</given-names> </author><author><surname>Ginsburg</surname> <given-names>H</given-names> </author><title>The malaria parasite supplies glutathione to its host cell: investigation of glutathione transport and metabolism in human erythrocytes infected with Plasmodium falciparum</title><source>Eur J Biochem</source><year>1997</year><volume>250</volume><fpage>670</fpage><lpage>679</lpage>
<author><surname>Barends</surname> <given-names>M</given-names> </author><author><surname>Jaidee</surname> <given-names>A</given-names> </author><author><surname>Khaohirun</surname> <given-names>N</given-names> </author><author><surname>Singhasivanon</surname> <given-names>P</given-names> </author><author><surname>Nosten</surname> <given-names>F</given-names> </author><title>In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border</title><source>Malar J</source><year>2007</year><volume>6</volume><fpage>81</fpage>
<author><surname>Basco</surname> <given-names>LK</given-names> </author><author><surname>Dechy-Cabaret</surname> <given-names>O</given-names> </author><author><surname>Ndounga</surname> <given-names>M</given-names> </author><author><surname>Meche</surname> <given-names>FS</given-names> </author><author><surname>Robert</surname> <given-names>A</given-names> </author><author><surname>Meunier</surname> <given-names>B</given-names> </author><title>In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates</title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><fpage>1886</fpage><lpage>1888</lpage>
<author><surname>Becker</surname> <given-names>K</given-names> </author><author><surname>Rahlfs</surname> <given-names>S</given-names> </author><author><surname>Nickel</surname> <given-names>C</given-names> </author><author><surname>Schirmer</surname> <given-names>RH</given-names> </author><title>Glutathione: functions and metabolism in the malarial parasite Plasmodium falciparum</title><source>Biol Chem</source><year>2003</year><volume>384</volume><fpage>551</fpage><lpage>566</lpage>
<author><surname>Bejon</surname> <given-names>P</given-names> </author><author><surname>Lusingu</surname> <given-names>J</given-names> </author><author><surname>Olotu</surname> <given-names>A</given-names> </author><author><surname>Leach</surname> <given-names>A</given-names> </author><author><surname>Lievens</surname> <given-names>M</given-names> </author><author><surname>Vekemans</surname> <given-names>J</given-names> </author><author><surname>Mshamu</surname> <given-names>S</given-names> </author><author><surname>Lang</surname> <given-names>T</given-names> </author><author><surname>Gould</surname> <given-names>J</given-names> </author><author><surname>Dubois</surname> <given-names>MC</given-names> </author><author><surname>Demoitie</surname> <given-names>MA</given-names> </author><author><surname>Stallaert</surname> <given-names>JF</given-names> </author><author><surname>Vansadia</surname> <given-names>P</given-names> </author><author><surname>Carter</surname> <given-names>T</given-names> </author><author><surname>Njuguna</surname> <given-names>P</given-names> </author><author><surname>Awuondo</surname> <given-names>KO</given-names> </author><author><surname>Malabeja</surname> <given-names>A</given-names> </author><author><surname>Abdul</surname> <given-names>O</given-names> </author><author><surname>Gesase</surname> <given-names>S</given-names> </author><author><surname>Mturi</surname> <given-names>N</given-names> </author><author><surname>Drakeley</surname> <given-names>CJ</given-names> </author><author><surname>Savarese</surname> <given-names>B</given-names> </author><author><surname>Villafana</surname> <given-names>T</given-names> </author><author><surname>Ballou</surname> <given-names>WR</given-names> </author><author><surname>Cohen</surname> <given-names>J</given-names> </author><author><surname>Riley</surname> <given-names>EM</given-names> </author><author><surname>Lemnge</surname> <given-names>MM</given-names> </author><author><surname>Marsh</surname> <given-names>K</given-names> </author><author><surname>von Seidlein</surname> <given-names>L</given-names> </author><title>Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age</title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>2521</fpage><lpage>2532</lpage>
<author><surname>Benoit-Vical</surname> <given-names>F</given-names> </author><author><surname>Lelievre</surname> <given-names>J</given-names> </author><author><surname>Berry</surname> <given-names>A</given-names> </author><author><surname>Deymier</surname> <given-names>C</given-names> </author><author><surname>Dechy-Cabaret</surname> <given-names>O</given-names> </author><author><surname>Cazelles</surname> <given-names>J</given-names> </author><author><surname>Loup</surname> <given-names>C</given-names> </author><author><surname>Robert</surname> <given-names>A</given-names> </author><author><surname>Magnaval</surname> <given-names>JF</given-names> </author><author><surname>Meunier</surname> <given-names>B</given-names> </author><title>Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes</title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><fpage>1463</fpage><lpage>1472</lpage>
<author><surname>Biot</surname> <given-names>C</given-names> </author><author><surname>Dessolin</surname> <given-names>J</given-names> </author><author><surname>Ricard</surname> <given-names>I</given-names> </author><author><surname>Dive</surname> <given-names>D</given-names> </author><title>Easily synthesized antimalarial ferrocene triazacyclononane quinoline conjugates</title><source>J Organomet Chem</source><year>2004</year><volume>689</volume><fpage>4678</fpage><lpage>4682</lpage>
<author><surname>Biot</surname> <given-names>C</given-names> </author><author><surname>Pradines</surname> <given-names>B</given-names> </author><author><surname>Sergeant</surname> <given-names>MH</given-names> </author><author><surname>Gut</surname> <given-names>J</given-names> </author><author><surname>Rosenthal</surname> <given-names>PJ</given-names> </author><author><surname>Chibale</surname> <given-names>K</given-names> </author><title>Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues</title><source>Bioorg Med Chem Lett</source><year>2007</year><volume>17</volume><fpage>6434</fpage><lpage>6438</lpage>
<author><surname>Bloland</surname> <given-names>PB</given-names> </author><source>Drug resistance in malaria</source><year>2001</year><other>Geneva</other><publisher>WHO, Malaria Epidemiology Branch, Centers for Disease Control and Prevention</publisher><fpage>1</fpage><lpage>23</lpage>
<author><surname>Bray</surname> <given-names>PG</given-names> </author><author><surname>Martin</surname> <given-names>RE</given-names> </author><author><surname>Tilley</surname> <given-names>L</given-names> </author><author><surname>Ward</surname> <given-names>SA</given-names> </author><author><surname>Kirk</surname> <given-names>K</given-names> </author><author><surname>Fidock</surname> <given-names>DA</given-names> </author><title>Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance</title><source>Mol Microbiol</source><year>2005</year><volume>56</volume><fpage>323</fpage><lpage>333</lpage>
<author><surname>Burgess</surname> <given-names>SJ</given-names> </author><author><surname>Selzer</surname> <given-names>A</given-names> </author><author><surname>Kelly</surname> <given-names>JX</given-names> </author><author><surname>Smilkstein</surname> <given-names>MJ</given-names> </author><author><surname>Riscoe</surname> <given-names>MK</given-names> </author><author><surname>Peyton</surname> <given-names>DH</given-names> </author><title>A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum</title><source>J Med Chem</source><year>2006</year><volume>49</volume><fpage>5623</fpage><lpage>5625</lpage>
<author><surname>Capela</surname> <given-names>R</given-names> </author><author><surname>Oliveira</surname> <given-names>R</given-names> </author><author><surname>Goncalves</surname> <given-names>LM</given-names> </author><author><surname>Domingos</surname> <given-names>A</given-names> </author><author><surname>Gut</surname> <given-names>J</given-names> </author><author><surname>Rosenthal</surname> <given-names>PJ</given-names> </author><author><surname>Lopes</surname> <given-names>F</given-names> </author><author><surname>Moreira</surname> <given-names>R</given-names> </author><title>Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition</title><source>Bioorg Med Chem Lett</source><year>2009</year><volume>19</volume><fpage>3229</fpage><lpage>3232</lpage>
<author><surname>Chipeleme</surname> <given-names>A</given-names> </author><author><surname>Gut</surname> <given-names>J</given-names> </author><author><surname>Rosenthal</surname> <given-names>PJ</given-names> </author><author><surname>Chibale</surname> <given-names>K</given-names> </author><title>Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum</title><source>Bioorg Med Chem</source><year>2007</year><volume>15</volume><fpage>273</fpage><lpage>282</lpage>
<author><surname>Chiyanzu</surname> <given-names>I</given-names> </author><author><surname>Clarkson</surname> <given-names>C</given-names> </author><author><surname>Smith</surname> <given-names>PJ</given-names> </author><author><surname>Lehman</surname> <given-names>J</given-names> </author><author><surname>Gut</surname> <given-names>J</given-names> </author><author><surname>Rosenthal</surname> <given-names>PJ</given-names> </author><author><surname>Chibale</surname> <given-names>K</given-names> </author><title>Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives</title><source>Bioorg Med Chem</source><year>2005</year><volume>13</volume><fpage>3249</fpage><lpage>3261</lpage>
<author><surname>Cosl&#233;dan</surname> <given-names>F</given-names> </author><author><surname>Fraisse</surname> <given-names>L</given-names> </author><author><surname>Pellet</surname> <given-names>A</given-names> </author><author><surname>Guillou</surname> <given-names>F</given-names> </author><author><surname>Mordmuller</surname> <given-names>B</given-names> </author><author><surname>Kremsner</surname> <given-names>PG</given-names> </author><author><surname>Moreno</surname> <given-names>A</given-names> </author><author><surname>Mazier</surname> <given-names>D</given-names> </author><author><surname>Maffrand</surname> <given-names>JP</given-names> </author><author><surname>Meunier</surname> <given-names>B</given-names> </author><title>Selection of a trioxaquine as an antimalarial drug candidate</title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>17579</fpage><lpage>17584</lpage>
<author><surname>Creek</surname> <given-names>DJ</given-names> </author><author><surname>Charman</surname> <given-names>WN</given-names> </author><author><surname>Chiu</surname> <given-names>FCK</given-names> </author><author><surname>Prankerd</surname> <given-names>RJ</given-names> </author><author><surname>Dong</surname> <given-names>Y</given-names> </author><author><surname>Vennerstrom</surname> <given-names>JL</given-names> </author><author><surname>Charman</surname> <given-names>SA</given-names> </author><title>Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials</title><source>Antimicrob Agents Chemother</source><year>2008</year><volume>52</volume><fpage>1291</fpage><lpage>1296</lpage>
<author><surname>Davioud-Charvet</surname> <given-names>E</given-names> </author><author><surname>Delarue</surname> <given-names>S</given-names> </author><author><surname>Biot</surname> <given-names>C</given-names> </author><author><surname>Schw&#246;bel</surname> <given-names>B</given-names> </author><author><surname>Boehme</surname> <given-names>CC</given-names> </author><author><surname>M&#252;ssigbrodt</surname> <given-names>A</given-names> </author><author><surname>Maes</surname> <given-names>L</given-names> </author><author><surname>Sergheraert</surname> <given-names>C</given-names> </author><author><surname>Grellier</surname> <given-names>P</given-names> </author><author><surname>Schirmer</surname> <given-names>RH</given-names> </author><author><surname>Becker</surname> <given-names>K</given-names> </author><title>A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline</title><source>J Med Chem</source><year>2001</year><volume>44</volume><fpage>4268</fpage><lpage>4276</lpage>
<author><surname>Eckstein-Ludwig</surname> <given-names>U</given-names> </author><author><surname>Webb</surname> <given-names>RJ</given-names> </author><author><surname>Van Goethem</surname> <given-names>ID</given-names> </author><author><surname>East</surname> <given-names>JM</given-names> </author><author><surname>Lee</surname> <given-names>AG</given-names> </author><author><surname>Kimura</surname> <given-names>M</given-names> </author><author><surname>O'Neill</surname> <given-names>PM</given-names> </author><author><surname>Bray</surname> <given-names>PG</given-names> </author><author><surname>Ward</surname> <given-names>SA</given-names> </author><author><surname>Krishna</surname> <given-names>S</given-names> </author><title>Artemisinins target the SERCA of Plasmodium falciparum</title><source>Nature</source><year>2003</year><volume>424</volume><fpage>957</fpage><lpage>961</lpage>
<author><surname>Ellis</surname> <given-names>GL</given-names> </author><author><surname>Amewu</surname> <given-names>R</given-names> </author><author><surname>Hall</surname> <given-names>C</given-names> </author><author><surname>Rimmer</surname> <given-names>K</given-names> </author><author><surname>Ward</surname> <given-names>SA</given-names> </author><author><surname>O'Neill</surname> <given-names>PM</given-names> </author><title>An efficient route into synthetically challenging bridged achiral 1,2,4,5-tetraoxanes with antimalarial activity</title><source>Bioorg Med Chem Lett</source><year>2008</year><volume>18</volume><fpage>1720</fpage><lpage>1724</lpage>
<author><surname>Foley</surname> <given-names>M</given-names> </author><author><surname>Tilley</surname> <given-names>L</given-names> </author><title>Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents</title><source>Pharmacol Ther</source><year>1998</year><volume>79</volume><fpage>55</fpage><lpage>87</lpage>
<author><surname>Gautam</surname> <given-names>A</given-names> </author><author><surname>Ahmed</surname> <given-names>T</given-names> </author><author><surname>Batra</surname> <given-names>V</given-names> </author><author><surname>Paliwal</surname> <given-names>J</given-names> </author><title>Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials</title><source>Curr Drug Metab</source><year>2009</year><volume>10</volume><fpage>289</fpage><lpage>306</lpage>
<author><surname>G&#243;mez</surname> <given-names>ZM</given-names> </author><author><surname>Rathod</surname> <given-names>PK</given-names> </author><title>Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice</title><source>Antimicrob Agents Chemother</source><year>1990</year><volume>34</volume><fpage>1371</fpage><lpage>1375</lpage>
<author><surname>Jones</surname> <given-names>M</given-names> </author><author><surname>Mercer</surname> <given-names>AE</given-names> </author><author><surname>Stocks</surname> <given-names>PA</given-names> </author><author><surname>La Pensee</surname> <given-names>LJ</given-names> </author><author><surname>Cosstick</surname> <given-names>R</given-names> </author><author><surname>Park</surname> <given-names>BK</given-names> </author><author><surname>Kennedy</surname> <given-names>ME</given-names> </author><author><surname>Piantanida</surname> <given-names>I</given-names> </author><author><surname>Ward</surname> <given-names>SA</given-names> </author><author><surname>Davies</surname> <given-names>J</given-names> </author><author><surname>Bray</surname> <given-names>PG</given-names> </author><author><surname>Rawe</surname> <given-names>SL</given-names> </author><author><surname>Baird</surname> <given-names>J</given-names> </author><author><surname>Charidza</surname> <given-names>T</given-names> </author><author><surname>Janneh</surname> <given-names>O</given-names> </author><author><surname>O'Neill</surname> <given-names>PM</given-names> </author><title>Antitumour and antimalarial activity of artemisinin-acridine hybrids</title><source>Bioorg Med Chem Lett</source><year>2009</year><volume>19</volume><fpage>2033</fpage><lpage>2037</lpage>
<author><surname>Kelly</surname> <given-names>JX</given-names> </author><author><surname>Smilkstein</surname> <given-names>MJ</given-names> </author><author><surname>Cooper</surname> <given-names>RA</given-names> </author><author><surname>Lane</surname> <given-names>KD</given-names> </author><author><surname>Johnson</surname> <given-names>RA</given-names> </author><author><surname>Janowsky</surname> <given-names>A</given-names> </author><author><surname>Dodean</surname> <given-names>RA</given-names> </author><author><surname>Hinrichs</surname> <given-names>DJ</given-names> </author><author><surname>Winter</surname> <given-names>R</given-names> </author><author><surname>Riscoe</surname> <given-names>M</given-names> </author><title>Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum</title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><fpage>4133</fpage><lpage>4140</lpage>
<author><surname>Kelly</surname> <given-names>JX</given-names> </author><author><surname>Smilkstein</surname> <given-names>MJ</given-names> </author><author><surname>Brun</surname> <given-names>R</given-names> </author><author><surname>Wittlin</surname> <given-names>S</given-names> </author><author><surname>Cooper</surname> <given-names>RA</given-names> </author><author><surname>Lane</surname> <given-names>KD</given-names> </author><author><surname>Janowsky</surname> <given-names>A</given-names> </author><author><surname>Johnson</surname> <given-names>RA</given-names> </author><author><surname>Dodean</surname> <given-names>RA</given-names> </author><author><surname>Winter</surname> <given-names>R</given-names> </author><author><surname>Hinrichs</surname> <given-names>DJ</given-names> </author><author><surname>Riscoe</surname> <given-names>MK</given-names> </author><title>An efficient route into synthetically challenging bridged achiral 1,2,4,5-tetraoxanes with antimalarial activity</title><source>Nature</source><year>2009</year><volume>459</volume><fpage>270</fpage><lpage>273</lpage>
<author><surname>Kouznetsov</surname> <given-names>VV</given-names> </author><author><surname>G&#243;mez-Barrio</surname> <given-names>A</given-names> </author><title>Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation</title><source>Eur J Med Chem</source><year>2009</year><volume>44</volume><fpage>3091</fpage><lpage>3113</lpage>
<author><surname>Loup</surname> <given-names>C</given-names> </author><author><surname>Lelievre</surname> <given-names>J</given-names> </author><author><surname>Benoit-Vical</surname> <given-names>F</given-names> </author><author><surname>Meunier</surname> <given-names>B</given-names> </author><title>Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine</title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><fpage>3768</fpage><lpage>3770</lpage>
<author><surname>Maher</surname> <given-names>B</given-names> </author><title>Malaria: the end of the beginning</title><source>Nature</source><year>2008</year><volume>451</volume><fpage>1042</fpage><lpage>1046</lpage>
<author><surname>Maude</surname> <given-names>RJ</given-names> </author><author><surname>Woodrow</surname> <given-names>CJ</given-names> </author><author><surname>White</surname> <given-names>LJ</given-names> </author><title>The artemisinin antimalarials: preserving the &#8220;magic bullet.&#8221;</title><source>Drug Dev Res</source><year>2010</year><volume>71</volume><fpage>12</fpage><lpage>19</lpage>(this issue)
<author><surname>Meierjohann</surname> <given-names>S</given-names> </author><author><surname>Walter</surname> <given-names>RD</given-names> </author><author><surname>Muller</surname> <given-names>S</given-names> </author><title>Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum</title><source>Biochem J</source><year>2002</year><volume>368</volume><fpage>761</fpage><lpage>768</lpage>
<author><surname>Meshnick</surname> <given-names>SR</given-names> </author><author><surname>Yang</surname> <given-names>YZ</given-names> </author><author><surname>Lima</surname> <given-names>V</given-names> </author><author><surname>Kuypers</surname> <given-names>F</given-names> </author><author><surname>Kamchonwongpaisan</surname> <given-names>S</given-names> </author><author><surname>Yuthavong</surname> <given-names>Y</given-names> </author><title>Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)</title><source>Antimicrob Agents Chemother</source><year>1993</year><volume>37</volume><fpage>1108</fpage><lpage>1114</lpage>
<author><surname>Morphy</surname> <given-names>R</given-names> </author><author><surname>Rankovic</surname> <given-names>Z</given-names> </author><title>Designed multiple ligands. An emerging drug discovery paradigm</title><source>J Med Chem</source><year>2005</year><volume>48</volume><fpage>6523</fpage><lpage>6543</lpage>
<author><surname>Muregi</surname> <given-names>FW</given-names> </author><author><surname>Kano</surname> <given-names>S</given-names> </author><author><surname>Kino</surname> <given-names>H</given-names> </author><author><surname>Ishih</surname> <given-names>A</given-names> </author><title>Plasmodiumberghei: efficacy of 5-fluoroorotate in combination with commonly used antimalarial drugs in a mouse model</title><source>Exp Parasitol</source><year>2009</year><volume>121</volume><fpage>376</fpage><lpage>380</lpage>
<author><surname>Noedl</surname> <given-names>H</given-names> </author><author><surname>Se</surname> <given-names>Y</given-names> </author><author><surname>Schaecher</surname> <given-names>K</given-names> </author><author><surname>Smith</surname> <given-names>BL</given-names> </author><author><surname>Socheat</surname> <given-names>D</given-names> </author><author><surname>Fukuda</surname> <given-names>MM</given-names> </author><title>Evidence of artemisinin-resistant malaria in western Cambodia</title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>2619</fpage><lpage>2620</lpage>
<author><surname>Nzila</surname> <given-names>A</given-names> </author><title>The past, present and future of antifolates in the treatment of Plasmodium falciparum infection</title><source>J Antimicrob Chemother</source><year>2006</year><volume>57</volume><fpage>1043</fpage><lpage>1054</lpage>
<author><surname>Nzila</surname> <given-names>A</given-names> </author><author><surname>Ward</surname> <given-names>SA</given-names> </author><author><surname>Marsh</surname> <given-names>K</given-names> </author><author><surname>Sims</surname> <given-names>PF</given-names> </author><author><surname>Hyde</surname> <given-names>JE</given-names> </author><title>Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy</title><source>Trends Parasitol</source><year>2005</year><volume>21</volume><fpage>292</fpage><lpage>298</lpage>
<author><surname>Olliaro</surname> <given-names>P</given-names> </author><author><surname>Wells</surname> <given-names>TN</given-names> </author><title>The global portfolio of new antimalarial medicines under development</title><source>Clin Pharmacol Ther</source><year>2009</year><volume>85</volume><fpage>584</fpage><lpage>595</lpage>
<author><surname>Olson</surname> <given-names>JE</given-names> </author><author><surname>Lee</surname> <given-names>GK</given-names> </author><author><surname>Semenov</surname> <given-names>A</given-names> </author><author><surname>Rosenthal</surname> <given-names>PJ</given-names> </author><title>Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors</title><source>Bioorg Med Chem</source><year>1999</year><volume>7</volume><fpage>633</fpage><lpage>638</lpage>
<author><surname>Pandey</surname> <given-names>AV</given-names> </author><author><surname>Tekwani</surname> <given-names>BL</given-names> </author><author><surname>Singh</surname> <given-names>RL</given-names> </author><author><surname>Chauhan</surname> <given-names>VS</given-names> </author><title>Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite</title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>19383</fpage><lpage>19388</lpage>
<author><surname>Perry</surname> <given-names>CS</given-names> </author><author><surname>Charman</surname> <given-names>SA</given-names> </author><author><surname>Prankerd</surname> <given-names>RJ</given-names> </author><author><surname>Chiu</surname> <given-names>FC</given-names> </author><author><surname>Dong</surname> <given-names>Y</given-names> </author><author><surname>Vennerstrom</surname> <given-names>JL</given-names> </author><author><surname>Charman</surname> <given-names>WN</given-names> </author><title>Chemical kinetics and aqueous degradation pathways of a new class of synthetic ozonide antimalarials</title><source>J Pharm Sci</source><year>2006</year><volume>95</volume><fpage>737</fpage><lpage>747</lpage>
<author><surname>Pukrittayakamee</surname> <given-names>S</given-names> </author><author><surname>Chotivanich</surname> <given-names>K</given-names> </author><author><surname>Chantra</surname> <given-names>A</given-names> </author><author><surname>Clemens</surname> <given-names>R</given-names> </author><author><surname>Looareesuwan</surname> <given-names>S</given-names> </author><author><surname>White</surname> <given-names>NJ</given-names> </author><title>Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria</title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><fpage>1329</fpage><lpage>1334</lpage>
<author><surname>Raji&#263;</surname> <given-names>Z</given-names> </author><author><surname>Kos</surname> <given-names>G</given-names> </author><author><surname>Zorc</surname> <given-names>B</given-names> </author><author><surname>Singh</surname> <given-names>PP</given-names> </author><author><surname>Singh</surname> <given-names>S</given-names> </author><title>Macromolecular prodrugs. XII. Primaquine conjugates: synthesis and preliminary antimalarial evaluation</title><source>Acta Pharm</source><year>2009</year><volume>59</volume><fpage>107</fpage><lpage>115</lpage>
<author><surname>Rathod</surname> <given-names>PK</given-names> </author><author><surname>G&#243;mez</surname> <given-names>ZM</given-names> </author><title>Plasmodiumyoelii: oral delivery of 5-fluoroorotate to treat malaria in mice</title><source>Exp Parasitol</source><year>1991</year><volume>73</volume><fpage>512</fpage><lpage>514</lpage>
<author><surname>Rathod</surname> <given-names>PK</given-names> </author><author><surname>Khatri</surname> <given-names>A</given-names> </author><author><surname>Hubbert</surname> <given-names>T</given-names> </author><author><surname>Milhous</surname> <given-names>WK</given-names> </author><title>Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro</title><source>Antimicrob Agents Chemother</source><year>1989</year><volume>33</volume><fpage>1090</fpage><lpage>1094</lpage>
<author><surname>Rathod</surname> <given-names>PK</given-names> </author><author><surname>Leffers</surname> <given-names>NP</given-names> </author><author><surname>Young</surname> <given-names>RD</given-names> </author><title>Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum</title><source>Antimicrob Agents Chemother</source><year>1992</year><volume>36</volume><fpage>704</fpage><lpage>711</lpage>
<author><surname>Robert</surname> <given-names>A</given-names> </author><author><surname>Meunier</surname> <given-names>B</given-names> </author><title>Is alkylation the main mechanism of action of the antimalarial drug artemisinin?</title><source>Chem Soc Rev</source><year>1998</year><volume>27</volume><fpage>273</fpage><lpage>279</lpage>
<author><surname>Rosenthal</surname> <given-names>PJ</given-names> </author><title>Antimalarial drug discovery: old and new approaches</title><source>J Exp Biol</source><year>2003</year><volume>206</volume><fpage>3735</fpage><lpage>3744</lpage>
<author><surname>Sabbani</surname> <given-names>S</given-names> </author><author><surname>Stocks</surname> <given-names>PA</given-names> </author><author><surname>Ellis</surname> <given-names>GL</given-names> </author><author><surname>Davies</surname> <given-names>J</given-names> </author><author><surname>Hedenstrom</surname> <given-names>E</given-names> </author><author><surname>Ward</surname> <given-names>SA</given-names> </author><author><surname>O'Neill</surname> <given-names>PM</given-names> </author><title>Piperidine dispiro-1,2,4-trioxane analogues</title><source>Bioorg Med Chem Lett</source><year>2008</year><volume>18</volume><fpage>5804</fpage><lpage>5808</lpage>
<author><surname>Sajid</surname> <given-names>M</given-names> </author><author><surname>McKerrow</surname> <given-names>JH</given-names> </author><title>Cysteine proteases of parasitic organisms</title><source>Mol Biochem Parasitol</source><year>2002</year><volume>120</volume><fpage>1</fpage><lpage>21</lpage>
<author><surname>Solomon</surname> <given-names>VR</given-names> </author><author><surname>Haq</surname> <given-names>W</given-names> </author><author><surname>Smilkstein</surname> <given-names>M</given-names> </author><author><surname>Srivastava</surname> <given-names>K</given-names> </author><author><surname>Rajakumar</surname> <given-names>S</given-names> </author><author><surname>Puri</surname> <given-names>SK</given-names> </author><author><surname>Katti</surname> <given-names>SB</given-names> </author><title>Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline</title><source>Med Chem</source><year>2008</year><volume>4</volume><fpage>446</fpage><lpage>456</lpage>
<author><surname>Uhlemann</surname> <given-names>AC</given-names> </author><author><surname>Wittlin</surname> <given-names>S</given-names> </author><author><surname>Matile</surname> <given-names>H</given-names> </author><author><surname>Bustamante</surname> <given-names>LY</given-names> </author><author><surname>Krishna</surname> <given-names>S</given-names> </author><title>Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277)</title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><fpage>667</fpage><lpage>672</lpage>
<author><surname>Vangapandu</surname> <given-names>S</given-names> </author><author><surname>Sachdeva</surname> <given-names>S</given-names> </author><author><surname>Jain</surname> <given-names>M</given-names> </author><author><surname>Singh</surname> <given-names>S</given-names> </author><author><surname>Singh</surname> <given-names>PP</given-names> </author><author><surname>Kaul</surname> <given-names>CL</given-names> </author><author><surname>Jain</surname> <given-names>R</given-names> </author><title>8-quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents</title><source>Bioorg Med Chem</source><year>2003</year><volume>11</volume><fpage>4557</fpage><lpage>4568</lpage>
<author><surname>Van Schalkwyk</surname> <given-names>DA</given-names> </author><author><surname>Egan</surname> <given-names>TJ</given-names> </author><title>Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum</title><source>Drug Resist Updat</source><year>2006</year><volume>9</volume><fpage>211</fpage><lpage>226</lpage>
<author><surname>Vennerstrom</surname> <given-names>JL</given-names> </author><author><surname>Arbe-Barnes</surname> <given-names>S</given-names> </author><author><surname>Brun</surname> <given-names>R</given-names> </author><author><surname>Charman</surname> <given-names>SA</given-names> </author><author><surname>Chiu</surname> <given-names>FC</given-names> </author><author><surname>Chollet</surname> <given-names>J</given-names> </author><author><surname>Dong</surname> <given-names>Y</given-names> </author><author><surname>Dorn</surname> <given-names>A</given-names> </author><author><surname>Hunziker</surname> <given-names>D</given-names> </author><author><surname>Matile</surname> <given-names>H</given-names> </author><author><surname>McIntosh</surname> <given-names>K</given-names> </author><author><surname>Padmanilayam</surname> <given-names>M</given-names> </author><author><surname>Santo Tomas</surname> <given-names>J</given-names> </author><author><surname>Scheurer</surname> <given-names>C</given-names> </author><author><surname>Scorneaux</surname> <given-names>B</given-names> </author><author><surname>Tang</surname> <given-names>Y</given-names> </author><author><surname>Urwyler</surname> <given-names>H</given-names> </author><author><surname>Wittlin</surname> <given-names>S</given-names> </author><author><surname>Charman</surname> <given-names>WN</given-names> </author><title>Identification of an antimalarial synthetic trioxolane drug development candidate</title><source>Nature</source><year>2004</year><volume>430</volume><fpage>900</fpage><lpage>904</lpage>
<author><surname>Wang</surname> <given-names>X</given-names> </author><author><surname>Dong</surname> <given-names>Y</given-names> </author><author><surname>Wittlin</surname> <given-names>S</given-names> </author><author><surname>Creek</surname> <given-names>D</given-names> </author><author><surname>Chollet</surname> <given-names>J</given-names> </author><author><surname>Charman</surname> <given-names>SA</given-names> </author><author><surname>Tomas</surname> <given-names>JS</given-names> </author><author><surname>Scheurer</surname> <given-names>C</given-names> </author><author><surname>Snyder</surname> <given-names>C</given-names> </author><author><surname>Vennerstrom</surname> <given-names>JL</given-names> </author><title>Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxides</title><source>J Med Chem</source><year>2007</year><volume>50</volume><fpage>5840</fpage><lpage>5847</lpage>
<author><surname>Wei</surname> <given-names>N</given-names> </author><author><surname>Sadrzadeh</surname> <given-names>SM</given-names> </author><title>Enhancement of hemin-induced membrane damage by artemisinin</title><source>Biochem Pharmacol</source><year>1994</year><volume>48</volume><fpage>737</fpage><lpage>741</lpage>
<author><surname>Wiwanitkit</surname> <given-names>V</given-names> </author><title>Plasmodium and host glutathione reductase: molecular function and biological process</title><source>Afr J Biotechnol</source><year>2006</year><volume>5</volume><fpage>2009</fpage><lpage>2013</lpage>
<author><surname>Zhou</surname> <given-names>L</given-names> </author><author><surname>Alker</surname> <given-names>A</given-names> </author><author><surname>Ruf</surname> <given-names>A</given-names> </author><author><surname>Wang</surname> <given-names>X</given-names> </author><author><surname>Chiu</surname> <given-names>FC</given-names> </author><author><surname>Morizzi</surname> <given-names>J</given-names> </author><author><surname>Charman</surname> <given-names>SA</given-names> </author><author><surname>Charman</surname> <given-names>WN</given-names> </author><author><surname>Scheurer</surname> <given-names>C</given-names> </author><author><surname>Wittlin</surname> <given-names>S</given-names> </author><author><surname>Dong</surname> <given-names>Y</given-names> </author><author><surname>Hunziker</surname> <given-names>D</given-names> </author><author><surname>Vennerstrom</surname> <given-names>JL</given-names> </author><title>Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277</title><source>Bioorg Med Chem Lett</source><year>2008</year><volume>18</volume><fpage>1555</fpage><lpage>1558</lpage>